Zepp Health Corporation Stock Price, News & Analysis

Zepp Health Corporation (NYSE: ZEPP) reported Q1 2022 revenue of RMB0.8 billion (US$119.4 million), a 34% decrease year-over-year, primarily due to decreased consumer spending and COVID-19 lockdowns in China. The company recorded a GAAP diluted net loss of RMB0.36 (US$0.06) per share, worsening from RMB0.16 in Q1 2021. Despite challenges, self-branded products accounted for over 65% of total revenue. The company launched new products and aims for net revenues of RMB1.08 billion to RMB1.30 billion in Q2 2022. As of March 31, 2022, cash reserves stood at RMB1.02 billion (US$161.2 million).

Zepp Health Corp. (NYSE: ZEPP) announced it will report its first quarter 2022 unaudited financial results before the market opens on May 24, 2022. The management will hold a conference call at 8:00 a.m. ET the same day, providing investors the opportunity to discuss results and future outlook. Zepp Health, a leader in smart wearable technology, aims to connect health with technology, having shipped 36 million units in 2021. For further details, investors can tune in to the live webcast or access a replay of the call following the event.

Zepp Health Corp. (NYSE: ZEPP) announced its identification by the SEC under the Holding Foreign Companies Accountable Act (HFCAA) on May 4, 2022. This occurred due to the use of an auditor whose working papers are not fully inspectable by the PCAOB. A company identified under HFCAA risks delisting if this continues for three consecutive years. Zepp Health is actively seeking to maintain its listing and protect stakeholder interests while complying with regulations in both China and the U.S.

Zepp Health Corp. (NYSE: ZEPP) has filed its annual report on Form 20-F for the fiscal year ending December 31, 2021. This report can be accessed on the Company's investor relations website and the SEC's website. Zepp Health is a leader in smart health technology, providing wearable devices and health analytics services. In 2021, it shipped 36 million units globally. The Company offers free hardcopies of the annual report to shareholders upon request.

Zepp Health has released its 2021 International Sleep White Paper, analyzing data from over 26 million global users. Key findings indicate that the global average sleep duration decreased to 7h09mins. Users in Belgium reported the longest sleep at 7.5 hours, while those in Indonesia had the least at 6h36mins. About 16.3% of users nap daily, with Vietnam, China, and Spain leading in this habit. The report emphasizes the importance of sleep for health, linking active lifestyles to better sleep quality.

Zepp Health achieved significant growth in Q4 2021, ranking among the top five in global adult watch shipments, as per IDC's report. The company shipped over 6.81 million adult watches worldwide, outpacing the overall market growth. Leading in Brazil and Turkey, Zepp also secured second place in Italy, Spain, the Czech Republic, and Indonesia. CEO Wayne Huang emphasized their commitment to leveraging technology for health empowerment. The Amazfit brand is recognized for its diverse offerings, with 11 models among the top 50.

Zepp Health Corporation (NYSE: ZEPP) reported Q4 2021 revenue of RMB1.66 billion (US$260.7 million), down 15.8% from Q4 2020. Despite a year-over-year increase in shipments of Amazfit and Zepp products by 14.3%, COVID-19 impacts and semiconductor shortages hindered overall sales. Full-year revenue totaled RMB6.25 billion, a 2.8% decrease from 2020. Net income for Q4 was RMB36.3 million, a decline from RMB115.2 million a year earlier. The company announced a special dividend of US$0.025 per share and continues a share repurchase program while navigating ongoing global challenges.

Zepp Health Corp. (NYSE: ZEPP) announced that it will release its fourth quarter and full year 2021 financial results on March 17, 2022, before market open. A conference call will follow at 8:00 a.m. ET the same day, accessible via various dialing options. The company, established in 2013, specializes in smart health technology, shipping 46 million units in 2020, including 33 million smart watches. Zepp Health aims to connect health with technology through proprietary AI chips, biometric sensors, and operating systems.

Amazfit, a brand of Zepp Health (NYSE: ZEPP), has launched a Valentine's Day gift guide featuring smart wearables designed to enhance health and connection. The guide highlights products such as the Amazfit GTR 3, GTS 3, and Bip U Series, all emphasizing heart rate monitoring and health management. An exclusive Valentine's Day Sale offers discounts up to 36%, running from January 26 to February 14, 2022, across various countries. The brand encourages customer engagement through social media activities, promising exciting prizes. For more details, visit their official website.